Daptomycin
Brand name: Daptomycin
Rank #287 of 500 drugs by total cost
$41.2M
Total Cost
41,245
Total Claims
$41.2M
Total Cost
1,296
Prescribers
$1,000
Cost per Claim
4,770
Beneficiaries
41,246
30-Day Fills
$32K
Avg Cost/Provider
32
Avg Claims/Provider
About Daptomycin
Daptomycin (sold as Daptomycin) was prescribed 41,245 times by 1,296 Medicare Part D providers in 2023, costing the program $41.2M. At $1,000 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 284 | Latanoprostene Bunod (Vyzulta) | $41.6M | 92,705 |
| 285 | Travoprost (Travoprost) | $41.5M | 178,599 |
| 286 | Alendronate Sodium (Alendronate Sodium) | $41.4M | 3,414,824 |
| 287 | Daptomycin (Daptomycin) | $41.2M | 41,245 |
| 288 | Pitavastatin Calcium (Livalo) | $40.8M | 69,636 |
| 289 | Bromfenac Sodium (Prolensa) | $40.8M | 121,284 |
| 290 | Suvorexant (Belsomra) | $40.7M | 87,327 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology